4van Domburg RT, Lemos PA,Takkenberg JM, et al. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. Eur Heart J,2005,26:675-681. 被引量：1
6Cook S, Togni M, Walpoth N, et al. Percutaneous Coronary Interventions in Europe 1992-2003. Eurolnterv,2006,1:374-379. 被引量：1
7Jensen LO, Maeng MI, Thayssen P, et al. Impact of drug eluting stents on target vessel revascularization. A report from the western Denmark heart registry from 2000 to 2004. Eurolnterv, 2006,1:391-395. 被引量：1
8Nagle PC, Smith AW. Review of recent US cost estimates of revascularization. Am J Manag Care, 2004,10:S370-S376. 被引量：1
9Touyz RM, Campbell N, Logan A, et al. The 2004 Canadian recommendations for the management of hypertention:part Ⅲ lifestyle modifications to prevent and control hypertention [J]. Canadian J Cadiol,2004 ,20 :559. 被引量：1
10Morisky DE, Ang A, Krousel-Wood M, Ward H. Pre- dictive Validity of a Medication Adherence Measure for Hypertension Control [ J ]. Journal of Clinical Hypertension 2008, 10(5) :348-354. 被引量：1
